Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-05-000001
Filing Date
2005-01-03
Accepted
2005-01-03 19:49:17
Documents
1
Period of Report
2004-12-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5153
  Complete submission text file 0000891293-05-000001.txt   7066
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 509 MADISON AVE 14TH FL NEW YORK NY 10022
Business Address DISCOVERY LABORATORIES INC 509 MADISON AVE 14TH FLOOR NEW YORK NY 10022 2122234504
LINK MAX (Reporting) CIK: 0001050944 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 05503751